Biopharma Co. Brass Sued Over 'Channel Stuffing' Disclosures
The top brass of pharmaceutical company ADMA Biologics Inc., among other things, failed to disclose certain related-party transactions the company engaged in and a channel-stuffing scheme to create the appearance of revenue, according...To view the full article, register now.
Already a subscriber? Click here to view full article